0001106644 – Page 8 – China Stock Advice

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:47:59+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:49:11+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]

By info| 2016-03-28T18:50:31+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer o Accelerated filer o

[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]

By info| 2016-03-28T18:51:24+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 8-K: (Original Filing)

[December 11, 2015 Office of the Chief Accountant 460 Fifth Street N.W. CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ARSHAK DAVTYAN, INC. ARSHAK DAVTYAN, INC. Salt Lake City, Utah December 11, 2015 EX-16.1 2 cphi8kex161121115.htm] [--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 4.02 Non-Reliance on Previously Issued Financial Statements or]

By info| 2016-03-28T18:58:48+00:00 December 11th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2015-12-11, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 8-K: December 11, 2015 Office of the Chief Accountant

[December 11, 2015 Office of the Chief Accountant 460 Fifth Street N.W. CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ARSHAK DAVTYAN, INC. ARSHAK DAVTYAN, INC. Salt Lake City, Utah December 11, 2015 EX-16.1 2 cphi8kex161121115.htm] [--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 4.02 Non-Reliance on Previously Issued Financial Statements or]

By info| 2016-03-28T19:00:53+00:00 December 11th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2015-12-11, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]

By info| 2016-03-28T19:02:19+00:00 December 10th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2015-12-10, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]

By info| 2016-03-28T19:05:07+00:00 December 10th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2015-12-10, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 75-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 16, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093015.htm]

By info| 2016-03-28T19:06:42+00:00 November 16th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2015-11-16, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q: FORM 10-Q (Mark One) x September 30, 2015

[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 75-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 16, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093015.htm]

By info| 2016-03-28T19:07:51+00:00 November 16th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2015-11-16, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments